Asmora(@asmora_mcp):BioMCP by @imaurer now enables biomedical agents to rapidly explore the treatment landscape for KRAS G12C-positive NSCLC using just seven CLI commands. By integrating data from 10+ biomedical sources, it retrieves therapeutic evidence, maps approved and investigational drugs, reviews FDA safety data, analyzes real-world adverse events, identifies recruiting clinical trials, and summarizes the latest resistance research all within a reproducible, end-to-end command-line workflow. Explore BioMCP on Asmora today:

2026.06.27 19:35

BioMCP by @imaurer now enables biomedical agents to rapidly explore the treatment landscape for KRAS G12C-positive NSCLC using just seven CLI commands. By integrating data from 10+ biomedical sources, it retrieves therapeutic evidence, maps approved and investigational drugs, reviews FDA safety data, analyzes real-world adverse events, identifies recruiting clinical trials, and summarizes the latest resistance research all within a reproducible, end-to-end command-line workflow. Explore BioMCP on Asmora today:

Ian Maurer 🧬@imaurer

2026.04.09 20:45

Biomedical agents can understand the treatment landscape for KRAS G12C-positive NSCLC by chaining together 7 BIOMCP commands. The below terminal-based screencast demonstrates the BioMCP commands that: * Orients across 1,741 known variants and 84 clinical trials * Pulls CIViC and ClinVar therapeutic evidence for G12C * Maps 5 drugs targeting KRAS (sotorasib, adagrasib, and 3 investigational) * Reviews sotorasib's FDA approval history and safety profile * Checks 2,465 real-world adverse event reports from FDA FAERS * Finds 62 recruiting trials for KRAS G12C NSCLC * Retrieves the latest research on resistance mechanisms 7 entity types. 10+ data sources. Under two minutes. Drugs, evidence, safety, trials, resistance -- the complete picture from a single CLI. Full walkthrough with every command and output: Documentation: GitHub Code repo: #BioMCP# #PrecisionOncology# #KRASG12C# #NSCLC# #AIAgents# #ClinicalGenomics#